Pregled bibliografske jedinice broj: 548026
Nesteroidni antireumatici i kardiovaskularni rizik
Nesteroidni antireumatici i kardiovaskularni rizik // Reumatizam, 57 (2010), 1; 26-28 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 548026 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Nesteroidni antireumatici i kardiovaskularni rizik
(Nonsteroidal anti-inflammatory drugs and the risk of cardiovascular diseases)
Autori
Jukič, A ; Martinović Kaliterna, Dušanka ; Radić, Mislav
Izvornik
Reumatizam (0374-1338) 57
(2010), 1;
26-28
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
nesteroidni antireumatici; kardiovaskularne bolesti
(Nonsteroidal anti-inflammatory drugs and the risk of cardiovascular diseases)
Sažetak
Non-steroidal anti-inflammatory drugs act as nonselective inhibitors of the enzyme cyclooxygenase (catalyzes the formation ofprostaglandins), inhibiting both the cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) isoenzymes. Selective COX-2 inhibitors have reduced gastrointestinal related adverse events but increased the risk of cardiovascular diseases. Selective COX-2 inhibitors may tip the natural balance between prothrombotic thromboxane A2 and antithrombotic prostacyclin potentially increasing the possibility of a thrombotic cardiovascular event. Decreased prostacycline synthesis, a vasodilatator and modulator of platelet activation, contributing to platelet aggregation and vasoconstriction. Some studies have suggested that NSAID increase the risk of cardiovascular events and for patients at high cardiovascular risk we should use them with great caution.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
198-1081874-0183 - Patogeneza sustavnih poremećaja u reumatoidnom artritisu (Morović-Vergles, Jadranka, MZOS ) ( CroRIS)
Ustanove:
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- MEDLINE